Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,085
Total Claims
$2.3M
Drug Cost
561
Beneficiaries
$4,169
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,961 Nephrology providers
+225%
Cost per patient vs peers
$4,169 vs $1,283 avg
+104%
Brand preference vs peers
18.3% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.2%
Opioid Rate
249
Opioid Claims
$4,767
Opioid Cost
4.4%
Long-Acting Rate
Brand vs Generic
Brand: 2,016 claims · $1.9M
Generic: 9,011 claims · $447K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Pegloticase | 11 | $648K |
| Finerenone | 120 | $106K |
| Dapagliflozin Propanediol | 80 | $102K |
| Calcifediol | 65 | $94K |
| Apixaban | 248 | $93K |
| Dulaglutide | 40 | $81K |
| Icosapent Ethyl | 73 | $57K |
| Empagliflozin | 46 | $48K |
| Sucroferric Oxyhydroxide | 13 | $43K |
| Linagliptin | 47 | $40K |
| Canagliflozin | 30 | $39K |
| Insulin Degludec | 26 | $38K |
| Sevelamer Carbonate | 49 | $38K |
| Sodium Zirconium Cyclosilicate | 51 | $38K |
| Sacubitril/Valsartan | 41 | $37K |
Prescribing Profile
Patient Profile
73
Avg Age
56%
Female
3.31
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About